CD8A and type 1 diabetes mellitus: This decrease in CD8+ T‐cell subpopulation, which was also observed with BL001‐treated mDCs, holds significant therapeutic implications given that CD8+ T‐cells are pivotal in beta cell destruction and sustained inflammation in T1D.101